Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malignant Hyperthermia | 3 | 2023 | 21 | 1.710 |
Why?
|
| Muscle, Skeletal | 5 | 2025 | 358 | 1.710 |
Why?
|
| Hyperglycemia | 2 | 2023 | 28 | 1.520 |
Why?
|
| Calcium | 5 | 2023 | 368 | 1.040 |
Why?
|
| Dengue Virus | 3 | 2020 | 5 | 1.010 |
Why?
|
| Glucose | 2 | 2023 | 48 | 0.900 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 173 | 0.810 |
Why?
|
| Myoblasts, Cardiac | 1 | 2020 | 1 | 0.730 |
Why?
|
| Dantrolene | 1 | 2020 | 2 | 0.730 |
Why?
|
| Calmodulin | 1 | 2020 | 6 | 0.730 |
Why?
|
| Cell Nucleus | 1 | 2020 | 71 | 0.720 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 90 | 0.700 |
Why?
|
| Animals | 8 | 2025 | 3389 | 0.640 |
Why?
|
| Interferon-beta | 1 | 2018 | 7 | 0.640 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 126 | 0.640 |
Why?
|
| Calcium Channels | 1 | 2018 | 107 | 0.600 |
Why?
|
| Glycogen | 2 | 2024 | 16 | 0.410 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2023 | 141 | 0.370 |
Why?
|
| Phosphorylation | 2 | 2020 | 133 | 0.350 |
Why?
|
| Calcium Signaling | 2 | 2022 | 118 | 0.350 |
Why?
|
| Rats | 3 | 2020 | 598 | 0.330 |
Why?
|
| Disease Susceptibility | 2 | 2023 | 66 | 0.260 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2023 | 39 | 0.250 |
Why?
|
| Muscular Diseases | 1 | 2025 | 16 | 0.240 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2023 | 14 | 0.210 |
Why?
|
| Mammals | 1 | 2023 | 22 | 0.210 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 13 | 0.210 |
Why?
|
| Mice | 3 | 2022 | 1280 | 0.200 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 7 | 0.200 |
Why?
|
| Cell Line | 2 | 2020 | 245 | 0.200 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2022 | 16 | 0.200 |
Why?
|
| Muscle Proteins | 1 | 2022 | 31 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 45 | 0.200 |
Why?
|
| Calcium Channels, L-Type | 1 | 2022 | 51 | 0.190 |
Why?
|
| STAT2 Transcription Factor | 1 | 2020 | 1 | 0.180 |
Why?
|
| Poly I-C | 1 | 2020 | 6 | 0.180 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2020 | 13 | 0.180 |
Why?
|
| Viral Proteins | 1 | 2020 | 12 | 0.180 |
Why?
|
| Cytosol | 1 | 2020 | 43 | 0.180 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2022 | 161 | 0.180 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2020 | 30 | 0.180 |
Why?
|
| Phosphorylase Kinase | 1 | 2020 | 4 | 0.180 |
Why?
|
| Glycogen Phosphorylase, Muscle Form | 1 | 2020 | 4 | 0.180 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2020 | 4 | 0.180 |
Why?
|
| Up-Regulation | 1 | 2020 | 151 | 0.170 |
Why?
|
| Humans | 5 | 2025 | 26025 | 0.170 |
Why?
|
| Blood Glucose | 1 | 2020 | 99 | 0.170 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2018 | 5 | 0.160 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2018 | 4 | 0.160 |
Why?
|
| Dengue | 1 | 2018 | 6 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 73 | 0.160 |
Why?
|
| Risk Factors | 1 | 2025 | 2243 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2018 | 70 | 0.150 |
Why?
|
| Cells, Cultured | 1 | 2018 | 475 | 0.140 |
Why?
|
| Signal Transduction | 1 | 2018 | 389 | 0.140 |
Why?
|
| Adult | 1 | 2020 | 7363 | 0.070 |
Why?
|
| Middle Aged | 1 | 2020 | 8507 | 0.070 |
Why?
|
| Aged | 1 | 2020 | 8704 | 0.070 |
Why?
|
| Microscopy, Electron | 1 | 2024 | 65 | 0.060 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 29 | 0.060 |
Why?
|
| Halothane | 1 | 2023 | 12 | 0.050 |
Why?
|
| Caffeine | 1 | 2023 | 52 | 0.050 |
Why?
|
| Muscle Contraction | 1 | 2023 | 66 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2022 | 44 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2022 | 73 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2022 | 25 | 0.050 |
Why?
|
| Models, Biological | 1 | 2015 | 304 | 0.030 |
Why?
|